GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Amikacin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

The source opening dose and its subsequent 15 mg/kg/day discussion are not interchangeable. Both are retained as historical text; no automatic aminoglycoside dose calculation is generated from them.

Check source scope before reading a dose

Stanford - extended-interval amikacin starting schedule

Product / population
Adults; gram-negative extended-interval method
Renal method
CrCl mL/min plus measured level
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Professional

Stanford - extended-interval amikacin starting schedule

Open original reference

Stanford Health Care · Adults; gram-negative extended-interval method

Renal method: CrCl mL/min plus measured level
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Adult initial amikacin: 15 mg/kg IV; CrCl >=60 every 24 hours, 40-59 every 36 hours, 30-39 every 48 hours. Not recommended below 30, HD or CRRT. Draw an 8-12-hour level, halve it for the Hartford graph, then individualize. Exclude pregnancy, major burns and significant ascites. This is not an NTM regimen.

RDM30-106-amikacin-1 · Source locator: Stanford - extended-interval amikacin starting schedule; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-Aminoglycoside-Dosing-Guide.pdf
Retrieved
2026-09-05
Renal-function method
CrCl mL/min plus measured level
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
798d3aa32af0846ba05e6834815f2cbb0d9e9b966aa3198ddaa1b3b31566be6e

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amikacin&s1=RDM30-106-amikacin&h1=ca38ad67a2e2a586d4f46eb70ca54f4364cac052223b383a333840d1daf935c6